The Bio Report

563 Episodes

1. Looking for a Better Alternative to Chemotherapy for AL Amyloidosis

   Published: 2/15/2018
2. A University Spin-Out that Incubates University Spin Outs

   Published: 2/8/2018
3. Understanding the Challenges and Opportunities of Patient-Centric Outcomes

   Published: 2/2/2018
4. How CellMax Hopes to Change the Diagnosis Cancer with Inexpensive Liquid Biopsy

   Published: 1/25/2018
5. How Surveillance and Data Are Bringing Precision to the Treatment of Prostate Cancer

   Published: 1/18/2018
6. Why Life Sciences M&A Should Heat up This Year

   Published: 1/11/2018
7. The Outlook for Biotech in 2018

   Published: 1/4/2018
8. The Year in Biotech and What to Watch in 2018

   Published: 12/28/2017
9. The Year in Immuno-Oncology and What to Watch in 2018

   Published: 12/21/2017
10. What the Approval of the First Digital Pill Means for the Future of Healthcare

    Published: 12/14/2017
11. Why Public Health Systems Need to Be Better Prepared for Extreme Weather Events

    Published: 12/7/2017
12. Former CDC Director Takes on World’s Leading Cause of Death

    Published: 11/30/2017
13. How a Public-Private Consortium Is Revolutionizing Cancer Drug Discovery

    Published: 11/23/2017
14. How Faulty Thinking Can Derail Life Sciences M&A Deals

    Published: 11/16/2017
15. Targeting Drug-Resistant Bacteria with an Ancient Enemy

    Published: 11/9/2017
16. A Bioelectronic Approach to Treating Autoimmune Diseases

    Published: 11/2/2017
17. Harnessing Patient Data to Improve Drug Development Efficiency

    Published: 10/26/2017
18. How Colorifix Is Trying to Turn the Textile Industry Green

    Published: 10/19/2017
19. Targeting Patients as Sick as Dogs

    Published: 10/12/2017
20. A Strategic Investor’s View of the Biotech Investment Landscape

    Published: 10/5/2017